Vitas-M small molecule compound
4,4'-{[5-(3,4-dichlorophenyl)furan-2-yl]methanediyl}bis(3-methyl-1H-pyrazol-5-ol)
Catalog ID
STK026154
SMILES Clc1ccc(cc1Cl)c1ccc(o1)C(c1c(O)[nH]nc1C)c1c(O)[nH]nc1C
Contact us by email for worldwide delivery information, pricing, and real‑time availability. Send us your quotation request, and we will confirm stock levels, provide exact costs and lead times, suggest alternatives or find analogs when helpful, and share any additional specifications you may need.
We supply compounds in quantities from 1 mg up to 5 g for research and development purposes only.
We do not supply quantities above 5 g.
Structure and other identifiers
2D representation rendered from the SMILES, with core physicochemical data.Formula C19H16Cl2N4O3 MW 419.27 g/mol Purity >90% as per NMR
InChI
InChI=1S/C19H16Cl2N4O3/c1-8-15(18(26)24-22-8)17(16-9(2)23-25-19(16)27)14-6-5-13(28-14)10-3-4-11(20)12(21)7-10/h3-7,17H,1-2H3,(H2,22,24,26)(H2,23,25,27)InChIKey
OETSMWAIDPRSGQ-UHFFFAOYSA-NSynonyms
4((5(34DICHLOROPHENYL)(2FURYL))(5HYDROXY3METHYLPYRAZOL4YL)METHYL)3METHYLPYRAZOL5OL
4((5(34DICHLOROPHENYL)2FURANYL)(3METHYL5OXO12DIHYDROPYRAZOL4YL)METHYL)5METHYL12DIHYDROPYRAZOL3ONE
4((5(34DICHLOROPHENYL)2FURYL)(3KETO5METHYL3PYRAZOLIN4YL)METHYL)5METHYL3PYRAZOLIN3ONE
4((5(34DICHLOROPHENYL)FURAN2YL)(3METHYL5OXIDANYLIDENE12DIHYDROPYRAZOL4YL)METHYL)5METHYL12DIHYDROPYRAZOL3ONE
4((5(34DICHLOROPHENYL)FURAN2YL)(3METHYL5OXO12DIHYDROPYRAZOL4YL)METHYL)5METHYL12DIHYDROPYRAZOL3ONE
44((5(34DICHLOROPHENYL)FURAN2YL)METHANEDIYL)BIS(3METHYL1HPYRAZOL5OL)
CC1=C(C(=O)NN1)C(C2=CC=C(O2)C3=CC(=C(C=C3)Cl)Cl)C4=C(NNC4=O)C
Clc1ccc(cc1Cl)c1ccc(o1)C(c1c(O)(nH)nc1C)c1c(O)(nH)nc1C
InChI=1SC19H16Cl2N4O3c1815(18(26)24228)17(169(2)232519(16)27)146513(2814)103411(20)12(21)710h3717H12H3(H2222426)(H2232527)
MFCD03992941
STK026154
ZINC000008670757
ZINC08670757
ZINC8670757
Check stock
See real-time availability and sample size for STK026154 on the Vitas-M platform.
Check stock on Vitas-MAvailable files
Download the SDF, MOL, 3D structure and SDS documents from Vitas-M.